Pharmafile Logo
Pharmafocus logo
Advanced Search
roche__tree

Roche’s cancer immunotherapy for lung cancer gets US FDA priority review

April 11, 2016
Business Services, Research and Development, Sales and Marketing Roche, US FDA, atezolizumab, lung cancer

Swiss drug firm Roche (SIX: ROG) on Monday said the US Food and Drug Administration (FDA) has accepted its Biologics …

News
chemo-web

Midatech launch treatment to reduce chemo-induced vomiting in the US

April 11, 2016
Research and Development, Sales and Marketing chemotherapy, midatech, nausea, oncology, radiation, vomiting

Midatech Pharma (NASDAQ: MTP) has the full commercial launch of Zuplenz (ondansetron) in the US. The drug is an oral …

News
640px-eye_iris

Sun Pharma receives FDA approval for ocular pain treatment

April 11, 2016
Research and Development, Sales and Marketing FDA, Sun Pharma, bromsite, ocular treatment

Sun Pharma (BSE: 524715) has announced that their ocular pain prevention treatment, BromSite (bromfenac ophthalmic solution), has been approved by …

News
celgene-logo

Celgene says disappointed with NICE decision to not back blood cancer drug

April 8, 2016
Business Services, Medical Communications, Sales and Marketing

US drugmaker Celgene Corp (Nasdaq: CELG) on Friday said it is disappointed with UK regulators’ decision to not recommend Vidaza …

News
hiv-infected_h9_t-cell_-_credit_national_institutes_of_health-web

HIV successfully overcomes CRISPR gene-editing technology

April 8, 2016
Research and Development HIV, crispr, failure, setback

Researchers using the CRISPR gene-editing technology have indicated that HIV can defeat efforts to cripple it, but have characterised it …

News
fda2outsideweb

US panel supports accelerated approval for Intercept’s trial drug for rare liver condition

April 8, 2016
Medical Communications, Research and Development, Sales and Marketing Intercept Pharmaceuticals, PDUFA, US FDA, liver disorder, rare disease

Intercept Pharmaceuticals (Nasdaq: ICPT) said a US Food and Drug Administration (FDA) advisory committee has recommended accelerated approval for its …

News
genome

UK’s genomics and personalised medicine expertise showcased at major international gathering

April 8, 2016
Manufacturing and Production, Research and Development 000 genomics project, 100, NHS, UK, expertise, genomics, international gathering, world leader

The UK’s expertise in genomics was showcased at a major international gathering to foster global collaboration in this burgeoning field. …

News

Pfizer, IBM partner to develop monitoring system for Parkinson’s disease

April 8, 2016
Medical Communications, Research and Development Parkinson's disease, Pfizer, collaboration, ibm, research, technology

US pharma giant Pfizer (NYSE: PFE) and International Business Machines Corp (NYSE: IBM) have partnered on a research project focussed on …

News
pharma_pill_manufacturing

AstraZeneca and Eli Lilly to enter Phase III on Alzheimer’s clinical trials

April 8, 2016
Medical Communications AZD3293, Alzheimer's, Alzheimers, AstraZeneca, amaranth, clinical trial, lilly, phase III

AstraZeneca and Eli Lilly have announced the continuation of their clinical trial for people with early Alzheimer’s disease into Phase …

News
apps_mobile

FTC launches tool to help mobile health app developers determine applicable regulations

April 8, 2016
Medical Communications, Sales and Marketing FDA, FTC, apps, health, health apps, regulation

The US Federal Trade Commission has created a new web-based tool for developers of health-related mobile apps to help them …

News

Vectura to get $10 million milestone as Hikma files ANDA for generic copy of GSK’s asthma drug

April 8, 2016
Medical Communications, Research and Development, Sales and Marketing

Vectura Group (LSE: VEC) on Friday said it is set to receive $10 million in milestone payments from partner Hikma …

News

Sandoz receives EU approval for subcutaneous injection of Binocrit biosimilar

April 8, 2016
Medical Communications, Research and Development Sandoz, binocrit, biosimilar, eu approval

Sandoz has received approval from the European Commission for a type II variation for the addition of a subcutaneous route …

News
bi_centre_03_2

Boehringer Ingelheim’s Giotrif gets Europan regulatory backing in another lung cancer indication

April 7, 2016
Business Services, Research and Development, Sales and Marketing Boehringer Ingelheim, European Commission, giotrif, lung cancer

German drugmaker Boehringer Ingelheim on Thursday said European regulators have granted marketing rights for its non-small cell lung cancer (NSCLC) …

News
clinical_trial_4

Clinical trials initiated for novel immunotherapy combo for ovarian cancer

April 7, 2016
Medical Communications, Research and Development MedImmune, cancer research institute, clinical trial, ludwig, ovarian cancer, ventirx

A cross collaboration between industry and not-for-profit organisations will see Ludwig Cancer Research and the Cancer Research Institute partner with …

News
eli_lilly_logo

Incyte buys rights to Eli Lilly’s Ruxolitinib; shares jump

April 7, 2016
Research and Development, Sales and Marketing Eli Lilly, Incyte, Licencing, M&A, MA, Novartis

Shares in Incyte Corp (Nasdaq: INCY) soared to close up over 11.5% Wednesday as the company said it has purchased …

News
foundry

UK’s first commercial synthetic biology foundry begins production

April 7, 2016
Manufacturing and Production, Research and Development Biological, biologics, foundry, synbicite

SynbiCITE’s has begun production at the UK’s first commercial synthetic biology foundry. The site provides automated end-to-end design, construction and …

News
shirelogo

Shire reassures Baxalta acquisition on track in the aftermath of Pfizer-Allergan breakup

April 7, 2016
Business Services, Sales and Marketing AbbVie, Allergan, Baxalta, Deals, Financial, Merger & Acquisition, Pfizer, Shire

Ireland-headquartered Shire Plc (LSE: SHP) has reassured its $32-billion merger deal with US-based Baxlata (NYSE: BXLT) remains on track in …

News
handshake

Allergan to partner with Heptares in Alzheimer’s disease collaboration

April 7, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Allergan, Alzheimer's, Heptares, R&D, collaboration, commercialisation, h1, h4, neurological disorders, partnership, research and development, treatments

Bouncing back quickly from the collapse of the collapse of the Pfizer inversion deal, Allergan (NYSE:AGN) has announced a new …

News

Novartis receives EU approval for blood disorder treatment in children

April 7, 2016
Research and Development, Sales and Marketing EMA, EU, ITP, Novartis, Revolade, approval, blood disorder, children, chronic itp

Novartis (NYSE: NVS) has announced that Revolade (eltrombopag) has been approved in the EU for use in paediatric patients aged …

News
pfizer_building

5 things to know about the Pfizer/Allergan inversion collapse

April 6, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 5, 5 things, Allergan, Pfizer, collapse, inversion, reasons

The end came very quickly for the Pfizer/Allergan $160 billion deal once the US Treasury Department announced a new set …

Feature
The Gateway to Local Adoption Series

Latest content

Campaign highlights low expectations among patients with depression

May 7, 2026

Practical AI toolkit launched to help manufacturers cut through complexity

May 6, 2026

Syngene appoints Maninder Kapoor Puri as CHRO

May 6, 2026

BioPhorum acquires PharmaX Solutions

May 5, 2026

Syngene appoints Abhijit Zutshi as CCO

May 5, 2026